Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amyris Inc (AMRS)

Amyris Inc (AMRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,469
  • Shares Outstanding, K 369,386
  • Annual Sales, $ 269,850 K
  • Annual Income, $ -528,510 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.19
  • Price/Sales 0.09
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.85
  • Most Recent Earnings $-0.34 on 05/09/23
  • Next Earnings Date 08/22/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.21
  • Number of Estimates 1
  • High Estimate 0.21
  • Low Estimate 0.21
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +145.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0500 unch
on 08/18/23
1.0650 -95.31%
on 07/19/23
-0.9800 (-95.15%)
since 07/18/23
3-Month
0.0500 unch
on 08/18/23
1.3200 -96.21%
on 06/16/23
-0.5357 (-91.46%)
since 05/18/23
52-Week
0.0500 unch
on 08/18/23
4.8600 -98.97%
on 09/15/22
-3.5000 (-98.59%)
since 08/18/22

Most Recent Stories

More News
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to...

AMRS : 0.0500 (-21.88%)
Is It Time to Buy This Year's Worst-Performing Growth Stocks?

Ready to make sense of the market's laggards? The share prices of these high-octane growth stocks are falling in 2023, so it might be time to bet on rebounds -- but only some of them.

CHGG : 2.0100 (+11.67%)
JD : 34.68 (-1.98%)
ENPH : 66.29 (+4.28%)
ETSY : 52.30 (+0.60%)
AMRS : 0.0500 (-21.88%)
AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCE

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE

EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable...

AMRS : 0.0500 (-21.88%)
AMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
Amyris May be Oversold, but is it Worth Fighting the Shorts?

Amyris is fighting a battle with short sellers, and with the economy either in, or nearing, a recession, there may be better options for speculative investors

AMRS : 0.0500 (-21.88%)
AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDAN

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS

Fourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was another record quarter. Core revenue of $75.8 million grew 17% over...

AMRS : 0.0500 (-21.88%)

Business Summary

Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged...

See More

Key Turning Points

3rd Resistance Point 0.0738
2nd Resistance Point 0.0691
1st Resistance Point 0.0595
Last Price 0.0500
1st Support Level 0.0452
2nd Support Level 0.0405
3rd Support Level 0.0309

See More

52-Week High 4.8600
Fibonacci 61.8% 3.0226
Fibonacci 50% 2.4550
Fibonacci 38.2% 1.8874
Last Price 0.0500
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar